Gland Pharma Ltd

NSE: GLAND BSE: 543245

₹2940.20

(0.73%)

Wed, 23 Sept 2026, 05:35 am

MTF 5xInvest in Gland Pharma Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)48861.47

PE Ratio42.94

Dividend0.68

Health Technology

Pharmaceuticals: Major

24.5K

Gland Pharma News

Gland Pharma fined ₹1.40 lakh for director appointment breach

Gland Pharma paid a combined ₹1.40 lakh penalty to NSE and BSE for a technical breach of SEBI LODR norms regarding the appointment of an independent director over 75. The company settled the full amount suo motu to ensure timely closure.

13 Sept 2026

companies

Gland Pharma to meet analysts and investors on Sept 11

Gland Pharma has scheduled a meeting with analysts and investors on September 11. The engagement reflects the company's ongoing investor relations activity.

08 Sept 2026

companies

Gland Pharma gets USFDA nod for Sugammadex

Gland Pharma Limited secures USFDA approval for Sugammadex Injection, a reversal agent with USD 1.6 billion US sales. The product launches Day 1 via marketing partner.

29 Jul 2026

companies

Gland Pharma: ₹51.59 Cr Block Trade on NSE

Gland Pharma sees a block trade of ₹51.59 crores on NSE involving ~209,098 shares at ₹2467.40 per share.

29 Jul 2026

equity-markets

Gland Pharma AGM set for Aug 25, 2026

Gland Pharma Limited has scheduled its 48th Annual General Meeting for August 25, 2026. The meeting will be held via video conferencing, with shareholders required to register email IDs to access documents.

28 Jul 2026

companies

Showing 1–5 of 90

Rows per page:

Market Current News

AceVector Files DRHP for Digital Commerce IPO

AceVector Limited, parent of Snapdeal and Unicommerce, filed its DRHP. The company reported FY2026 revenue of ₹510.38 crore with losses narrowing to ₹45.51 crore.

22 Sept 2026

ipo

Orient Cables IPO: ₹552 Cr Issue; 33% Rev CAGR

Orient Cables (India) Limited files DRHP for a ₹552 crore IPO. The company reports a 33.45% revenue CAGR and holds ~22.9% market share in networking cables.

22 Sept 2026

ipo

German Green Steel DRHP: ₹226 Cr Capex

Gujarat-based German Green Steel & Power files DRHP for fresh issue. Proceeds fund capacity expansion and hybrid power plant. Revenue grew at 21.91% CAGR.

22 Sept 2026

ipo

Runwal Enterprises IPO: Mumbai's 3rd Largest Developer

Runwal Enterprises files DRHP for IPO. Revenue rose 78.5% to ₹1,798.95 Cr in FY26. Proceeds aim to reduce debt by ₹325 Cr.

22 Sept 2026

ipo

Green Asia Impex DRHP: ₹40 Cr Capex Plan

Frozen seafood exporter Green Asia Impex files DRHP for SME IPO. Fresh issue funds new processing facility. Revenue grew to ₹383.80 Cr in FY26, but operating cash flows remain negative.

22 Sept 2026

ipo

Showing 1–5 of 94338

Rows per page: